First Drug-Free Option for ADHD Cleared in America
For the first time, children in the United States will have a non-drug option for treating attention deficit hyperactivity disorder (ADHD). The FDA just cleared the Monarch external Trigeminal Nerve Stimulation (eTNS) System from NeuroSigma, a Los An...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Neurology Pediatrics Psychiatry Rehab Source Type: blogs
More News: ADHD | Brain | Child Development | Children | Depression | Epilepsy | Hyperactivity | Medical Devices | Men | Neurology | Pain | Pediatrics | Post Traumatic Stress Disorder | Psychiatry | USA Health